4 recruiting. 2 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 2 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow BL-M14D1: new trials by email Literature Review of BL-M14D1 trials Research Report on BL-M14D1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01) BL-M14D1 and Atezolizumab, Carboplatin+ Etoposide + Atezolizumab followed by Atezolizumab and Lurbinectedin - Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer | Phase 3 | Recruiting | SystImmune Inc. | 550 | 2026-08-04 | 2026-11-12 |
| A Study of BL-M14D1 in Combination With Atezolizumab in Patients With Extensive-stage Small Cell Lung Cancer BL-M14D1, Atezolizumab - Extensive-stage Small-cell Lung Cancer | Phase 2 | Recruiting | Biokin (Shanghai) Biopharmaceutical Co., Ltd. | 36 | 2026-07-09 | 2026-11-02 |
| Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors BL-M14D1 - Small Cell Lung Cancer Metastatic or Locally Advanced, Neuroendocrine Cancer | Phase 1 | Recruiting | SystImmune Inc. | 120 | 2025-04-28 | 2026-11-12 |
| A Study of BL-M14D1 in Patients With Locally Advanced or Metastatic Small Cell Lung Cancer, Neuroendocrine Tumors and Other Solid Tumors BL-M14D1 - Small Cell Lung Cancer, Neuroendocrine Tumors | Phase 1 | Recruiting | Biokin (Shanghai) Biopharmaceutical Co., Ltd. | 115 | 2024-08-02 | 2026-11-02 |
Small Cell Lung Carcinoma (3) · Carcinoma, Neuroendocrine (1) · Carcinoma, Small Cell (1) · Lung Neoplasms (1) · Neuroendocrine Tumors (1)
Biokin (Shanghai) Biopharmaceutical Co., Ltd. (2) · SystImmune Inc. (2)
China (2) · Georgia (2) · United States (2) · Australia (1) · Bulgaria (1) · Canada (1) · Czechia (1) · France (1) · Germany (1) · Greece (1) · Hungary (1) · India (1) · Italy (1) · Poland (1) · Serbia (1)
Caicun Zhou (1) · Junliang Cai (1) · Junliang Cai, MD (1)